Full Text View
Tabular View
No Study Results Posted
Related Studies
Quetiapine for the Reduction of Cocaine Use (AZC)
This study has been completed.
Study NCT00631748   Information provided by Seattle Institute for Biomedical and Clinical Research

First Received on March 3, 2008.   Last Updated on November 25, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cocaine Dependence
Cocaine Abuse
Cocaine Addiction
Drug Abuse
Substance Abuse
Additional conditions recognized in this trial
Behavior, Addictive
Cocaine-Related Disorders
Substance-Related Disorders
More general conditions related to this trial
Compulsive Behavior
Impulsive Behavior
Mental Disorders
Interventions listed in this trial
quetiapine fumarate
Matched Placebo
Cognitive-behavioral Therapy
Additional drug interventions recognized in this trial
Cocaine
Quetiapine
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Antipsychotic Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Vasoconstrictor Agents
Sponsors listed in this trial
Seattle Institute for Biomedical and Clinical Research
VA Puget Sound Health Care System
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services